TEM
Tempus AI, Inc. · Healthcare · Medical - Healthcare Information Services
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 105 | -4 | 78.05M | $4.52B | +6 | −11 |
| Q1 2026 | 113 | -8 | 69.19M | $3.11B | +9 | −18 |
| Q4 2025 | 122 | 0 | 71.01M | $4.19B | +2 | −1 |
| Q3 2025 | 19 | +1 | 54.18M | $4.37B | +2 | −2 |
| Q2 2025 | 16 | +5 | 35.66M | $2.27B | +6 | −1 |
| Q1 2025 | 8 | +2 | 9.48M | $457.55M | +3 | −1 |
| Q4 2024 | 6 | +1 | 7.54M | $254.48M | +2 | −1 |
| Q3 2024 | 5 | -2 | 10.12M | $572.43M | n/a | −2 |
| Q2 2024 | 7 | n/a | 7.72M | $270.21M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 5.23M | n/a | $182.95M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Norges Bank ✦ (passive) | 1.05M | n/a | $36.75M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | ARK Investment Management ✦ | 522.70K | n/a | $18.29M | 0.2% | n/c | 1 | SEC ↗ |
| 4 | Citadel Advisors ✦ | 418.57K | n/a | $14.65M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 5 | Millennium Management ✦ | 230.49K | n/a | $8.07M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Marshall Wace ✦ | 138.88K | n/a | $4.86M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Geode Capital Management ✦ (passive) | 132.63K | n/a | $4.64M | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1 holders, 13.60K shares, $614 reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 10.28K sh · $873,885
Officer, Director, 10% owner · 6.43K sh · $492,422
Officer, Director, 10% owner · 24 sh · $1,893
Officer, Director, 10% owner · 2.09K sh · $163,579
Officer, Director, 10% owner · 33.77K sh · $2.61M
Officer, Director, 10% owner · 17.36K sh · $1.33M
Officer, Director, 10% owner · 29.37K sh · $2.27M
Officer, Director, 10% owner · 965 sh · $73,890
Officer, Director, 10% owner · 37.95K sh · $2.97M
Officer, Director, 10% owner · 4.42K sh · $341,622
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology